SeaCrest Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

SeaCrest Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,500	Closed	-$26K	–	2152
2018 Q4	$26K	Buy	1,500 +1,000	+200%	+$17.1K	0.01%	1130
2018 Q3	$7K	Sell	500 -100	-17%	-$1.77K	﹤0.01%	1756
2018 Q2	$14K	Sell	600 -1,250	-68%	-$30.7K	﹤0.01%	1486
2018 Q1	$47K	Sell	1,850 -650	-26%	-$15.5K	0.01%	974
2017 Q4	$46K	Buy	+2,500	New	+$35.8K	0.01%	993

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SeaCrest Wealth Management's COLL Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of Collegium Pharmaceutical (COLL) in Q1 2019, closing a stake of 1,500 shares — an estimated $26K sold.

SeaCrest Wealth Management first reported a position in COLL in Q4 2017 and held it in 5 quarters. The position peaked at $47K in Q1 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

SeaCrest Wealth Management reported no remaining Collegium Pharmaceutical position as of Q1 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 1,500 Collegium Pharmaceutical shares in Q1 2019, an estimated $26K.
SeaCrest Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 5 quarters.
SeaCrest Wealth Management's Collegium Pharmaceutical position peaked at $47K in Q1 2018.
145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.